Fernando Gonzalez-Ortiz

1 month ago | alz-journals.onlinelibrary.wiley.com | Yara Yakoub |Fernando Gonzalez-Ortiz |Nicholas Ashton |Christine Déry

1 BACKGROUND The core pathological hallmarks that define Alzheimer's disease (AD) are plaque-forming aggregates of amyloid beta (Aβ) and neurofibrillary tangles of hyper-phosphorylated tau (p-tau).

Dec 5, 2024 | onlinelibrary.wiley.com | Fernando Gonzalez-Ortiz |Region Västra Götaland |Lukas Holmegaard |Björn Andersson

Introduction Stroke continues to be a major cause of disability and mortality globally, and incidence among people younger than 70 years of age is increasing [1]. Despite advances in diagnostic modalities and treatments, accurate prognostication remains a significant challenge.

Oct 25, 2024 | journals.sagepub.com | Julia Gundersen |Fernando Gonzalez-Ortiz |Thomas K. Karikari |Bjørn-Eivind Kirsebom

Introduction Acute ischemic stroke (AIS), a leading cause of mortality and long-term disability, poses an enormous global burden.1,2 Thrombolysis and thrombectomy are highly effective but time-sensitive treatments that improve long-term outcome after AIS.3 Approximately 25% of patients presenting with AIS have a non-ischemic neurological or non-neurological condition, such as peripheral vestibular dysfunction (23.2%), seizures (13.0%) functional disorders (9.7%) and migraine (7.8%).4...

Aug 7, 2024 | medrxiv.org | Fernando Gonzalez-Ortiz |Yara Yakoub |Julia K Gundersen |Bjorn-Eivind Kirsebom

The authors have declared no competing interest. Authors funding information is provided in the manuscriptI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

May 9, 2024 | medrxiv.org | Fernando Gonzalez-Ortiz |Nicholas Ashton |Yara Yakoub |Christine Déry

HZ has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio,...